Every heartbeat depends on four heart valves opening and closing perfectly to ensure blood flows in the right direction. When one of these valves becomes narrowed (stenosis) or leaky (regurgitation), the heart must work harder, eventually leading to breathlessness, fatigue, chest pain, dizziness, heart failure, or even sudden death if left untreated.
The good news is that treating valve disease has evolved dramatically over the past decade. Today, many patients no longer require conventional open-heart surgery. Advances in structural heart interventions now allow selected patients to undergo Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Replacement (TMVR), and Transcatheter Edge-to-Edge Repair (TEER) through small catheters, often with quicker recovery and excellent outcomes.
The heart has four valves:
• Aortic Valve
• Mitral Valve
• Tricuspid Valve
• Pulmonary Valve
These valves ensure one-way blood flow.
Valve disease develops when a valve becomes:
Stenotic – fails to open completely.
Regurgitant – fails to close properly.
Both conditions increase the workload on the heart and can eventually lead to heart failure.
Patients may experience:
• Shortness of breath
• Chest pain
• Fatigue
• Palpitations
• Dizziness or fainting
• Swelling of feet
• Reduced exercise capacity
Many patients dismiss these symptoms as "old age," delaying treatment until heart function has already deteriorated.
Treatment depends on:
• Severity of valve disease
• Symptoms
• Age
• Surgical risk
• Heart function
• Other medical conditions
Today, treatment is individualized by a multidisciplinary Heart Team, including interventional cardiologists, cardiac surgeons, imaging specialists, anesthesiologists, and heart failure experts.
1. Surgical Valve Repair
Whenever feasible, repairing the native valve is preferred, especially in degenerative mitral valve disease, as it preserves the patient's own valve and may reduce the need for lifelong anticoagulation.
2. Surgical Valve Replacement (SAVR)
Open-heart valve replacement remains an excellent option for many younger and low-risk patients with severe valve disease.
Mechanical valves offer excellent durability but require lifelong blood thinners, while biological valves avoid long-term anticoagulation but have a limited lifespan.
3. Transcatheter Aortic Valve Replacement (TAVR)
One of the biggest advances in cardiology is TAVR, where a new aortic valve is implanted through a catheter, usually inserted via the femoral artery in the groin—without opening the chest.
TAVR is especially beneficial for:
• Severe aortic stenosis
• Elderly patients
• High-risk surgical candidates
• Intermediate-risk patients
• Selected younger patients after Heart Team evaluation
Advantages
• No large chest incision
• Faster recovery
• Shorter hospital stay
• Less pain
• Early return to normal activities
• Excellent long-term outcomes
For appropriately selected patients, TAVR has outcomes comparable to surgery while offering a less invasive treatment option.
4. Transcatheter Mitral Valve Repair (TEER)
Patients with severe mitral regurgitation who are unsuitable for surgery may benefit from TEER, a minimally invasive procedure performed through a catheter inserted via the femoral vein.
This technique clips the leaking mitral valve leaflets together, reducing regurgitation and improving symptoms without open-heart surgery.
TEER has transformed the management of selected patients with both degenerative and functional mitral regurgitation.
5. Transcatheter Mitral Valve Replacement (TMVR)
TMVR is an emerging treatment option for selected patients with severe mitral valve disease who are not suitable for conventional surgery.
It may be considered in:
• Degenerated bioprosthetic valves
• Failed surgical mitral repairs
• Severe mitral annular calcification
• Selected native mitral valve disease
Although currently offered in specialized centers for carefully selected patients, TMVR represents the future of structural heart interventions.
6. Valve-in-Valve Procedures
Patients who previously underwent valve replacement do not always require repeat open-heart surgery when the bioprosthetic valve degenerates.
Using catheter-based technology, a new valve can often be implanted inside the old valve through Valve-in-Valve TAVR or Valve-in-Valve TMVR, avoiding another major operation.
Compared with conventional surgery, catheter-based valve therapies offer several potential advantages:
• Smaller puncture instead of a large surgical incision
• Faster recovery
• Shorter hospital stay
• Less blood loss
• Reduced postoperative pain
• Earlier return to work and daily activities
• Excellent clinical outcomes in appropriately selected patients
Recovery depends on the procedure performed.
Most patients undergoing TAVR, TMVR,TEER begin walking within 24 hours and are discharged in 1–3 days if there are no complications. Recovery after surgical valve replacement generally requires a longer hospital stay and several weeks of rehabilitation.
Valve disease often progresses silently.
Regular evaluation with:
• Clinical examination
• Echocardiography
• Cardiac CT
• Cardiac MRI (selected cases)
• Coronary angiography when indicated
helps identify the optimal time for intervention—before irreversible heart damage occurs.
Successful outcomes depend on more than the procedure itself. Comprehensive structural heart programs provide:
• Advanced cardiac imaging
• Heart Team discussions
• Personalized treatment planning
• Surgical and catheter-based options under one roof
• Long-term follow-up and rehabilitation
This ensures that each patient receives the most appropriate treatment rather than a one-size-fits-all approach.
At Star Hospitals, we offer comprehensive evaluation and advanced treatment for heart valve disease, including TAVR, TMVR, TEER, valve-in-valve procedures, and surgical valve interventions. Using state-of-the-art imaging, a multidisciplinary Heart Team approach, and internationally accepted treatment protocols, we tailor therapy to each patient's clinical needs.
Whether you require conventional surgery or the latest minimally invasive structural heart intervention, our goal is to restore heart function, improve quality of life, and help you return to normal activities as quickly and safely as possible.